Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.pdfH1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.
  2. Press release.pdfPress Release

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 32 / 2025
Date of issue: 2025-07-24
Short name of the issuer
KRKA
Subject
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the Unaudited Interim Financial Report of the Krka Group and Krka, d. d., Novo mesto for the six months ended 30 June 2025.


The report will be published on the Company's website (www.krka.biz) from 24 July 2025 onwards, for a minimum 10 years.
Annexes
File Description
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.pdf
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.pdf
H1 2025 Unaudited Interim Report of the Krka Group and Krka, d. d.
Press release.pdf
Press release.pdf
Press Release

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-07-24 Jože Colarič President of the Management Board and CEO
20250724_081832_0833598435_H1_2025_Unaudited_Interim_Report_of_the_Krka_Group_and_Krka,_d._d.pdf

20250724_081832_0833598435_Press_release.pdf